December was a topsy turvy month for crypto, but growing stablecoin reserves could hint at a fresh rally as Trump's ...

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.

Aldoro led resources stock gains in December on strong niobium sampling results at its Kameelburg project in Namibia.

Settling on a name for a mineral deposit isn’t quite as important as naming a child but it’s clear some are more creative ...

The high-risk strategies employed by aggressive growth funds have paid off in a bumper year for members. Analysis by ...

In this episode of the Unicorns podcast, Justin talks with Mark Schneider, Chief Nuclear Officer at UBH Group.

Aussie shares moved up on Thursday. Energy stocks led, Lendlease dipped, Brainchip soared, and the AUD hit a two-year low.